MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- FORTIS HEALTHCARE (hospital & healthcare services)
- FORTIS HEALTHCARE Financial Data
FORTIS HEALTHCARE Fact Sheet 
(FORTIS)
Discover: The 5-Minute Blueprint for Becoming a ONE STOCK CROREPATI
Here is the latest financial fact sheet of FORTIS HEALTHCARE. For more details, see the FORTIS HEALTHCARE quarterly results and FORTIS HEALTHCARE share price and chart.
FORTIS HEALTHCARE Price History
| 1 Day | % | 4.7 |
| No. of shares | m | 754.96 |
| 1 Week | % | 8.3 |
| 1 Month | % | 2.9 |
| 1 Year | % | 1.2 |
| 52 week H/L | Rs | 313.8/219.8 |
FORTIS HEALTHCARE Financials
| No. of Mths Year Ending |
12 Mar-17* |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
5-Yr Chart Click to enlarge
|
|---|
| FORTIS HEALTHCARE EQUITY SHARE DATA | |||||||
|---|---|---|---|---|---|---|---|
| High | Rs | 205 | 231 | 161 | 169 | 217 | |
| Low | Rs | 143 | 107 | 125 | 112 | 113 | |
| Sales per share (Unadj.) | Rs | 88.3 | 87.9 | 59.2 | 61.4 | 53.4 | |
| Earnings per share (Unadj.) | Rs | -0.1 | -19.0 | -7.8 | 1.1 | -1.4 | |
| Diluted earnings per share | Rs | -0.1 | -13.1 | -7.8 | 1.1 | -1.4 | |
| Cash flow per share (Unadj.) | Rs | 4.2 | -14.4 | -4.7 | 4.9 | 2.5 | |
| Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
| Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
| Book value per share (Unadj.) | Rs | 99.0 | 77.8 | 87.1 | 88.2 | 81.0 | |
| Adj. book value per share | Rs | 67.9 | 53.4 | 87.1 | 88.2 | 81.0 | |
| Shares outstanding (eoy) | m | 517.73 | 518.66 | 754.96 | 754.96 | 754.96 | |
| Price / Sales ratio | x | 2.0 | 1.9 | 2.4 | 2.3 | 3.1 | |
| Avg P/E ratio | x | -1,329.0 | -8.9 | -18.3 | 133.5 | -120.0 | |
| P/CF ratio (eoy) | x | 41.8 | -11.7 | -30.3 | 28.5 | 66.6 | |
| Price / Book Value ratio | x | 1.8 | 2.2 | 1.6 | 1.6 | 2.0 | |
| Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
| Avg Mkt Cap | Rs m | 89,981 | 87,536 | 107,751 | 105,921 | 124,493 | |
| Total wages/salary | Rs m | 9,054 | 8,991 | 9,136 | 9,160 | 8,490 | |
| FORTIS HEALTHCARE INCOME DATA | |||||||
|---|---|---|---|---|---|---|---|
| Net Sales | Rs m | 45,737 | 45,608 | 44,694 | 46,323 | 40,301 | |
| Other income | Rs m | 1,660 | 1,397 | 924 | 526 | 466 | |
| Total revenues | Rs m | 47,397 | 47,005 | 45,618 | 46,850 | 40,767 | |
| Gross profit | Rs m | 3,512 | -6,079 | 28 | 6,713 | 4,057 | |
| Depreciation | Rs m | 2,222 | 2,390 | 2,329 | 2,917 | 2,906 | |
| Interest | Rs m | 2,294 | 2,578 | 3,368 | 2,051 | 1,659 | |
| Profit before tax | Rs m | 656 | -9,649 | -4,745 | 2,272 | -43 | |
| Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
| Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
| Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
| Tax | Rs m | 724 | 227 | 1,136 | 1,479 | 995 | |
| Profit after tax | Rs m | -68 | -9,876 | -5,881 | 793 | -1,037 | |
| Gross profit margin | % | 7.7 | -13.3 | 0.1 | 14.5 | 10.1 | |
| Effective tax rate | % | 110.3 | -2.3 | -23.9 | 65.1 | -2,333.2 | |
| Net profit margin | % | -0.1 | -21.7 | -13.2 | 1.7 | -2.6 | |
| FORTIS HEALTHCARE BALANCE SHEET DATA | |||||||
|---|---|---|---|---|---|---|---|
| Current assets | Rs m | 17,748 | 12,815 | 16,666 | 9,405 | 10,368 | |
| Current liabilities | Rs m | 19,265 | 21,340 | 35,910 | 25,789 | 12,330 | |
| Net working cap to sales | % | -3.3 | -18.7 | -43.1 | -35.4 | -4.9 | |
| Current ratio | x | 0.9 | 0.6 | 0.5 | 0.4 | 0.8 | |
| Inventory Days | Days | 193 | 173 | 79 | 79 | 71 | |
| Debtors Days | Days | 377 | 376 | 443 | 361 | 353 | |
| Net fixed assets | Rs m | 77,090 | 70,451 | 98,194 | 100,145 | 97,477 | |
| Share capital | Rs m | 5,177 | 5,187 | 7,550 | 7,550 | 7,550 | |
| "Free" reserves | Rs m | 46,084 | 35,150 | 58,221 | 59,024 | 53,629 | |
| Net worth | Rs m | 51,261 | 40,336 | 65,771 | 66,574 | 61,179 | |
| Long term debt | Rs m | 12,787 | 9,481 | 6,371 | 9,541 | 9,677 | |
| Total assets | Rs m | 94,838 | 83,266 | 114,859 | 109,549 | 107,845 | |
| Interest coverage | x | 1.3 | -2.7 | -0.4 | 2.1 | 1.0 | |
| Debt to equity ratio | x | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | |
| Sales to assets ratio | x | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | |
| Return on assets | % | 2.3 | -8.8 | -2.2 | 2.6 | 0.6 | |
| Return on equity | % | -0.1 | -24.5 | -8.9 | 1.2 | -1.7 | |
| Return on capital | % | 4.6 | -14.2 | -1.9 | 5.7 | 2.3 | |
| Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
| Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
| Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
| Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
| Fx inflow | Rs m | 0 | 158 | 73 | 82 | 21 | |
| Fx outflow | Rs m | 0 | 175 | 11 | 48 | 11 | |
| Net fx | Rs m | 0 | -17 | 62 | 33 | 10 | |
| FORTIS HEALTHCARE CASH FLOW | |||||||
|---|---|---|---|---|---|---|---|
| From Operations | Rs m | 9,665 | 4,929 | -1,785 | 1,715 | 4,855 | |
| From Investments | Rs m | -10,016 | -3,354 | -33,227 | 604 | -1,351 | |
| From Financial Activity | Rs m | 2,594 | -6,720 | 42,566 | -8,616 | -1,429 | |
| Net Cashflow | Rs m | 2,245 | -5,126 | 7,988 | -6,266 | 2,120 | |
Share Holding
Shareholding as on Mar 2022
|
Company Information
|
|||||||||||||||||||||||||||||||||||||
| CHM: Ravi Rajagopal | COMP SEC: Murlee Manohar Jain | YEAR OF INC: 1996 | BSE CODE: 532843 | FV (Rs): 10 | DIV YIELD (%): - |
More Hospital & Healthcare Services Company Fact Sheets: ADANI PORTS & SEZ GOKUL AGRO RESOURCES TIME TECHNO POLYCAB INDIA RELAXO FOOTWEARS
Compare FORTIS HEALTHCARE With: ADANI PORTS & SEZ GOKUL AGRO RESOURCES TIME TECHNO POLYCAB INDIA RELAXO FOOTWEARS
Today's Market
Sensex Zooms 400 Points, Nifty Trades Above 16,000; Titan Rallies 6%(10:30 am)
Asian share markets mostly opened higher today after minutes from a Federal Reserve meeting showed that US central bankers are determined to fight inflation despite recession worries.
Views on news
5 Indian Companies Embracing Blockchain Technology (Views On News)
Jul 6, 2022Blockchain adoption in India was slow in the past. Now, the technology is being well received.
5 Stocks That Stand to Gain Big from a Weakening Rupee (Views On News)
Jun 30, 2022As the rupee depreciates, these Indian companies stand to benefit the most.
The 4 Strongest Companies in the Tata Group. Add Them to Your Watchlist (Views On News)
Jun 30, 2022Check out these four Tata group companies that have the strongest performance and fundamentals.
4 Companies that Turned Profitable in 2022. Here's How They did it... (Views On News)
Jun 29, 2022These companies posted a net profit after posting losses for consecutive years. Here's their mantra.
3 Indian Companies Which Have Announced Big Dividend Payouts in 2022 (Views On News)
Jun 21, 2022Investing in dividend paying stocks is more relevant in the current environment where uncertainty is ruling the stock market.
More Views on NewsMost Popular
5 Indian Companies where Mutual Fund Holdings are Consistently Increasing (Views On News)
Jul 1, 2022Mutual funds are buying shares at a time when FIIs are consistently selling. Here are 5 stocks where MF holdings has increased for the past 4 quarters.
Auto Stocks are in the Fast Lane. Is it Time to Buy? (Profit Hunter)
Jun 23, 2022The auto index is outperforming the Nifty by a mile. Have auto stocks finally bottomed out?
Forget FIIs. Follow These Experts to Navigate the Market (Profit Hunter)
Jun 24, 2022How you deal with the recent correction is going to be a great differentiator in your net worth.
Why Crude Oil Price is Falling (Views On News)
Jun 25, 2022Global markets have become volatile, sending chills through the crude oil market.
The 4 Strongest Companies in the Tata Group. Add Them to Your Watchlist (Views On News)
Jun 30, 2022Check out these four Tata group companies that have the strongest performance and fundamentals.
MoreOUR TOP 5 IDEAS
TRACK FORTIS HEALTHCARE
- Track your investment in FORTIS HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON FORTIS HEALTHCARE
FORTIS HEALTHCARE - DR LALCHANDANI LABS COMPARISON
COMPARE FORTIS HEALTHCARE WITH
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
- Multibagger Penny Stocks
- Basics of Value Investing
- Benjamin Graham
- How to Invest in Gold
- How to Invest in Silver
- Best Stocks to Buy Today
- Best Small-cap Stocks to Buy
- Best Bluechip Stocks to Buy
- Guide to Penny Stocks
- How to Invest in the Share Market
- Warren Buffett - The Value Investor
- Pick the Best Multibagger Stocks in 2022
TRENDING TOPICS
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.